Pharmaceutical & Biotechnology

//Pharmaceutical & Biotechnology

Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts

One of the strongest performing biopharmaceutical stocks this year is [...]

Verona (VRNA) Talks Up The Long View Following Phase II Setback

Verona Pharma (NASDAQ:VRNA) highlighted a surprising benefit from a lower [...]

ADMA Biologics Believes It Can Resolve CRL Issues Quickly, Spring Review Possible

Shares of ADMA Biologics [NASDAQ:ADMA]  fell more than 45% on [...]

ADMA Biologics Receives a Split FDA Decision on BIVIGAM

ADMA Biologics (NASDAQ:ADMA), a company specializing in the manufacturing and development [...]

ADMA Biologics (NASDAQ:ADMA) December Catalyst: PDUFA for BIVIGAM

SanaCurrents assigns a pivotal sentiment the FDA will approve the [...]

Hemophilia Treatment Company Catalyst Biosciences’ Antibody Update May Catalyze Shares

Catalyst Biosciences, Inc. (NASDAQ:CBIO) , a company that is developing improved [...]

Karyopharm’s Cancer Drug Achieves Impressive Results

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) reported impressive results on December 1, 2018 [...]

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) – 3Q 2019 catalyst, CBD treatment for Fragile X

3Q ‘19 catalyst, CBD treatment for Fragile X SanaCurrents is [...]